G. N. Ithakisiou

High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing

M. C. Hagemeijer, J. Beekman, C. K. van der Ent, 2022, ERJ Open Research.

FDA-Approved Drug Screening in Patient-Derived Organoids Demonstrates Potential of Drug Repurposing for Rare Cystic Fibrosis Genotypes

H. Oppelaar, E. Dompeling, E. Weersink, 2022, bioRxiv.